期刊文献+

弓形虫SAG1单抗的研制及其初步应用 被引量:3

Preparation of monoclonal antibodies against Toxoplasma gondii and its preliminary application
原文传递
导出
摘要 为开展弓形虫免疫诊断及抗弓形虫感染的相关研究,利用可溶性表达的弓形虫表面抗原SAG1截短型重组蛋白(trSAG1)研制单克隆抗体,筛选出能够稳定分泌高滴度抗体的杂交瘤细胞株,所分泌的单抗不仅适用于在虫体定位该蛋白,而且具有一定的小鼠体内保护作用。共筛选出4株(6H1、6G12、7B4和7A12)特异性好的单抗分泌株,经亚型测定,4株单抗重链均为IgG1,轻链均为κ链。抗体经纯化后测定效价为1∶8 000~1∶25 600;Western blot结果显示4株单抗能够同时识别重组表达及天然弓形虫SAG1抗原。筛选得到的2株抗SAG1单抗(6H1和7B4)可用于间接免疫荧光检测SAG1蛋白在虫体中的表达定位和分布。小鼠被动免疫保护试验表明,6H1和7B4两株单抗分别或联合使用可稍微延长被弓形虫感染的小鼠的存活时间。本试验研制的弓形虫SAG1单克隆抗体对将来研究弓形虫蛋白定位、弓形虫感染的诊断及防治具有一定的应用价值。 To develop the detection methods for Toxoplasma gondii, monoclonal antibodies (McAbs) to T. gondii major surface antigen SAG1 were generated, and screened and identified. Four strains of hybridoma cells including 6H1, 6G12, 71M and 7A12 which had good specificity against T. gondii were obtained. The subtypes of all the four McAbs were determined. The heavy chains were IgG1 and the light chains were K-chain. Four McAbs were purified and the titers were from 1 : 8 000 to 1 : 25 600. Western blot analysis demonstrated that all the four McAbs reacted strongly and specifically with recombinant and tachyzoite native SAG1 antigen of T. gondii, but not with pET Trx pro- tein. McAbs 6H1 and 7B4 were applicable for the immunofluorescent observation of SAG1 in tachyzoite. The immune protection tests also in- dicated that both 6H1 and 7B4 could prolong the survival time of the challenged mice. Our results indicated that the two McAbs will be useful in further studies for SAG1 location in T. gondiii, and diagnosis and treatment of toxoplasmosis.
出处 《畜牧与兽医》 北大核心 2013年第5期9-13,共5页 Animal Husbandry & Veterinary Medicine
基金 中央级公益性科研院所基本科研业务费专项资金(2013JB10) 公益性行业(农业)科研专项经费(201303045)
关键词 弓形虫 SAG1 单克隆抗体 免疫荧光检测 免疫保护 Toxoplasma gondii major surface antigen SAG1 monoclonal antibody immunofluorescent observation protective immunity
  • 相关文献

参考文献12

  • 1Blader I J, Saeij J P. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune eva- sion and virulence [J]. APMIS, 2009, 117 : 458-476.
  • 2Tenter A M, Heckewth A R, Weiss L M. Toxoplasma gondii: from animals to humans [J]. Int J Parasitol, 2000, 30: 1217-1258.
  • 3Harning D, Spenter J, Metsis A, et al. Recombinant Toxoplasma gondii surface antigen 1 (I0) expressed in Escheriehia coli is rec- ognized by human Toxoplasma-specific immunoglobulin M (lgM) and IgG antibodies [ J]. Clin Diagn Lab lmmunol, 1996, 3: 355-357.
  • 4Mohamed R M, Aosai F, Chen M, et al. Induction of protective im-munity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes [J]. Vaccine, 2003, 21 : 2852-2861.
  • 5Siachoque H, Guzman F, Burgos J, et al. Toxoplasma gondii: im- munogenicity and protection by P30 peptides in a murine model [J]. Exp Parasitol, 2006, 114: 62-65.
  • 6Wu K, Chen X G, Li H, et al. Diagnosis of human toxoplasmosis by using the recombinant truncated surface antigen 1 of Toxoplasma gon- dii [J]. Diagn Microbiol Infect Dis, 2009, 64: 261-266.
  • 7Araujo P R B, Ferreira A W. Avidity of IgG antibodies against ex- creted / secreted antigens of Toxoplasma gondii: immunological marker for acute recent toxoplasmosis [ J ]. Rev Soc Bras Med, 2008, 41 : 142-147.
  • 8刘钊,禹海杰,卓洵辉,周前进,杜爱芳.抗弓形虫MIC3单抗的制备及其在速殖子免疫荧光观察中的应用[J].中国兽医科学,2011,41(10):1030-1033. 被引量:4
  • 9Angus C W, Klivingt on -Evans D, Dubey J P, et al. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplas- ma gondii is immunogenic and protective in rodents [ J ]. J Infect Dis, 2000, 181(1) : 317-324.
  • 10Meng M, t-Ie S, Zhao G, et al. Evaluation of protective immune re- sponses induced by DNA vaccines encoding Toxoplasma gondii sur- face antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice [ J]. Parasit Vectors, 2012, 5 : 273.

二级参考文献20

  • 1徐大刚.弓形虫P30基因及其功能[J].中国兽医寄生虫病,2002,10(3):42-45. 被引量:8
  • 2周怀瑜,何深一,丛华,古钦民,李瑛,赵群力,杨婷婷,张加勤.弓形虫P30与佐剂CTA_2/B复合基因酵母表达载体的构建与生物信息学分析[J].中国寄生虫病防治杂志,2005,18(2):88-91. 被引量:5
  • 3BOOTHROYD J C. Tozoplasma gondii:25 years and 25 major advances for the field[J]. Int J Parasitol, 2009,39 (8) :935-946.
  • 4PEREIRA-CHIOCCOLA V L, VIDAL J E, SU C. Toxoplasma gondii infection and cerebral toxoplasmosis in H|V-infected patients[J]. Future Microbio1,2009,4(10) : 1363-1379.
  • 5SOLDATI D, DUBREMETZ J F, LEBRUN M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite To:coplasma gondii[J]. Int J Parasito1,2001,31(12 ) :1293-1302.
  • 6GARCIA-REGUET N, LEBRUN M, FOURMAUX M N, et al. The microneme protein MIC3 of Toxoplasrna gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite[J].Cell Microbio1,2000,2 (4) :353-364.
  • 7QU D, YU H, WANG S,et al. Induction of protective immuni ty by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against To.voplasma gondii infection in mice[J]. Vet Parasitol,2009,166(3/4) :220-227.
  • 8CEREDE O, DUBREMETZ J F, BOUT D, et al. The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin[J].EMBO J, 2002, 21 (11) :2526 -2536.
  • 9DOWSE T,SOLDATI D. Host cell invasion by the apicomplexans:the significance of mieroneme protein proteolysis[J].Curr Opin Microbiol, 2004,7 (4) : 388 -396.
  • 10Mt-VELEC M N, DUCOURNAU C, ISMAEL A B, et al. Micl-3 Knockout Toxoplasrna gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep[J]. Vet Res, 2010,41(4) :49.

共引文献10

同被引文献38

  • 1Behnke MS, Zhang TP, Dubey JP, et al. Toxoplasma gondii mer- ozoite gene expression analysis with comparison to the life cycle discloses a unique expression state during enteric development [J]. BMC Genomics, 2014, 15(1): 350.
  • 2Cong H, Zhang M, Zhang Q, et al. Analysis of structures and epit- opes of surface antigen glycoproteins expressed in bradyzoites of Toxoplasma gondii [J]. Biomed Res Int, 2013 : 165342.
  • 3Wang Y, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii [J]. Parasit Vectors, 2014, 7 : 180.
  • 4Burg JL, Perelman D, Kasper LH, et al. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii [J]. I Immunol, 1988, 141(10) : 3584-3591.
  • 5Kim K, Bulow R, Kampmeier J, et al. Conformationally appropri- ate expression of the Toxoplasma antigen SAG1 (P30) in CHO cells [J]. Infect Immun, 1994, 62( 1 ) : 203-209.
  • 6Letscher-Bru V, Villard O, Risse B, et al. Protective effect of vac- cination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice [J]. Infect Immun, 1988, 66(9) : 4503-4506.
  • 7Angus CW, Klivington-Evans D, Dubey JP, et al. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxo- plasma gondii is immunogenic and protective in rodents [J]. J In- fect Dis, 2000, 181(1): 317-324.
  • 8Gallego C, Saavedra-Matiz C, Gomez-Marin JE. Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America) [J]. Acta Trop, 2006, 97(2) : 161-167.
  • 9Howe DK, Sibley LD. Toxoplasma gondii comprises three elonal lineages: correlation of parasite genotype with human disease [J]. J Infect Dis, 1995, 172(6) : 1561-1566.
  • 10Prince JB, Auer KL, Huskinson J, et al. Cloning, expression and cDNA sequence of surface antigen P22 from Toxoplasma gondii [J]. MolBioehem Parasitol, 1990, 43(1): 97-106.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部